De Benedictis Fernando Maria, Selvaggio David
Department of Pediatrics, "Salesi" Children's Hospital, Ancona, Italy.
Paediatr Drugs. 2003;5(9):629-38. doi: 10.2165/00148581-200305090-00005.
Inhalation is the preferred route for asthma therapy, since it offers a rapid onset of drug action, requires smaller doses, and reduces systemic effects compared with other routes of administration. Unfortunately, inhalation devices are frequently used in an empirical manner rather than on evidence-based awareness.A wide variety of nebulizers are available. Conventional jet nebulizers are highly inefficient, as much of the aerosol is wasted during exhalation. However, incorporating an extra open vent into the system has considerably increased the amount of drug that patients receive. Breath-assisted open vent nebulizers limit the loss of aerosol during exhalation, but are dependent on the patient's inspiratory flow. Ultrasonic nebulizers produce a high mass output and have a short nebulization time, but are inefficient for delivering suspensions or viscous solutions. Adaptive aerosol delivery devices release a precise dose that is tailored to the individual patient's breathing pattern. Nebulizers have several drawbacks, and their use should be limited to patients who cannot correctly manage other devices.Pressurized metered-dose inhalers (pMDI) are practical, cheap and multidose. However, there are several problems with their use. Breath-actuated MDI are easy to use and can be activated by very low flow. However, young children may not be able to use them efficiently. Dry powder inhalers (DPI) are portable and easy to use. They are indicated either for rescue bronchodilator therapy or for regular treatment with inhaled corticosteroids and long-acting bronchodilators. The use of spacers reduces oropharyngeal deposition and improves drug delivery to the lung. Spacers do not require patient coordination, but some general rules must be followed for their optimal use.Thus, the choice of a delivery device mainly depends on the age of the patient, the drug to be administered and the condition to be treated. Proper education is also essential when prescribing an inhalation device.
吸入是哮喘治疗的首选途径,因为与其他给药途径相比,它起效迅速、所需剂量较小且全身效应降低。不幸的是,吸入装置的使用往往是经验性的,而非基于循证认知。市面上有各种各样的雾化器。传统喷射雾化器效率极低,因为许多气雾剂在呼气过程中被浪费了。然而,在系统中加入一个额外的开放通气口,大大增加了患者所接受的药物量。呼吸辅助开放通气雾化器可减少呼气时气雾剂的损失,但依赖于患者的吸气流量。超声雾化器产生的质量输出高且雾化时间短,但在输送混悬液或粘性溶液方面效率较低。自适应气雾剂输送装置可根据个体患者的呼吸模式释放精确剂量。雾化器有几个缺点,其使用应限于无法正确使用其他装置的患者。压力定量吸入器(pMDI)实用、便宜且为多剂量。然而,其使用存在几个问题。呼吸驱动的MDI易于使用,且可由极低流量激活。然而,幼儿可能无法有效使用它们。干粉吸入器(DPI)便于携带且易于使用。它们适用于抢救性支气管扩张剂治疗或用于吸入性糖皮质激素和长效支气管扩张剂的常规治疗。使用储物罐可减少口咽部沉积并改善药物向肺部的输送。储物罐不需要患者配合,但为了最佳使用必须遵循一些一般规则。因此,给药装置 的选择主要取决于患者年龄、待给药药物和待治疗病症。在开具吸入装置处方时,适当的教育也至关重要。